The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Inflammation, stress, and diabetes
Open accessAbstract
Over the last decade, an abundance of evidence has emerged demonstrating a close link between metabolism and immunity.It is now clear that obesity is associated with a state of chronic low-level inflammation.In this article, we discuss the molecular and cellular underpinnings of obesity-induced inflammation and the signaling pathways at the intersection of metabolism and inflammation that contribute to diabetes.We also consider mechanisms through which the inflammatory response may be initiated and discuss the reasons for the inflammatory response in obesity.We put forth for consideration some hypotheses regarding important unanswered questions in the field and suggest a model for the integration of inflammatory and metabolic pathways in metabolic disease. Inflammation, stress, and diabetesSurvival of multicellular organisms depends on the ability to fight infection and heal damage and the ability to store energy for times of low nutrient availability or high energy need.Metabolic and immune systems are therefore among the most basic requirements across the animal kingdom, and many nutrient and pathogen-sensing systems have been highly conserved from organisms such as Caenorhabditis elegans and Drosophila to mammals.Perhaps not surprisingly, metabolic and immune pathways have also evolved to be closely linked and interdependent.Many hormones, cytokines, signaling proteins, transcription factors, and bioactive lipids can function in both metabolic and immune roles.In addition to using some of the same cellular machinery, metabolic and immune systems also regulate each other.The normal inflammatory response relies upon metabolic support, and energy redistribution, particularly the mobilization of stored lipid, plays an important role in fighting infection during the acute-phase response (1).The basic inflammatory response thus favors a catabolic state and suppresses anabolic pathways, such as the highly conserved and powerful insulin signaling pathway.The integration of metabolism and immunity, which under normal conditions is beneficial for the maintenance of good health, can become deleterious under conditions of metabolic challenge, as exemplified by the immunosuppression characteristic of malnourished or starving individuals (1-3).Famine has been a prominent hazard to human health throughout history, and for thousands of years the link between infection and poor nutrition has been well recognized.Today this threat is as widespread as ever, and there are approximately 1 billion undernourished individuals worldwide (3).In the past century, however, the pendulum has also swung in the opposite direction, and now as many if not more people are overweight or obese (4).With the advent of this chronic metabolic overload, a new set of problems and complications at the intersection of metabolism and immunity has emerged, including the obesity-linked inflammatory diseases diabetes, fatty liver disease, airway inflammation, and atherosclerosis (5).There is now a wealth of evidence indicating close ties between metabolic and immune systems.Among the many reasons to
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies have also suggested that visceral adiposity may play an important role in causing hepatic insulin resistance through its release of fatty acids and adipocytokines to the liver via the portal vein (28-31).”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,024
Shao-Ling, W. A. N. G., Ying, L. I., Wen, Y., Yan-Feng, C. H. E. N., Na, L.-X., Li, S., & Sun, C. (2009) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(09)60019-2 · Cited by 163
Moloney, F., Toomey, S., Noone, E., Nugent, A. P., Allan, B. B., Loscher, C. E., & Roche, H. M. (2007) · Diabetes · doi:10.2337/db06-0384 · Cited by 160
Recio, C., Lucy, D., Purvis, G. S. D., Iveson, P., Zeboudj, L., Iqbal, A. J., Lin, D., O’Callaghan, C. A., Davison, L. J., Griesbach, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01419 · Cited by 166
Role of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and Obesity
Ndisang, J. F. (2010) · Mediators of Inflammation · doi:10.1155/2010/359732 · Cited by 160
Protein Tyrosine Phosphatase 1B (PTP1B) and Obesity
Cho, H. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00017-1 · Cited by 158
Goto, M. (2008) · PubMed · Cited by 154
Cucak, H., Grunnet, L. G., & Rosendahl, A. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0213075 · Cited by 162
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 160
Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes
Grisanti, L. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01669 · Cited by 160
Randeria, S. N., Thomson, G. J. A., Nell, T. A., Roberts, T. J., & Pretorius, E. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0870-9 · Cited by 157
Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus
Akash, M. S. H., Shen, Q., Rehman, K., & Chen, S. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23057 · Cited by 158
Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy
Kashyap, D., Sharma, A. K., Sak, K., Tuli, H. S., Buttar, H. S., & Bishayee, A. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.12.005 · Cited by 154
Libert, S., Chao, Y., Chu, X., & Pletcher, S. D. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00251.x · Cited by 155
Adipokines Linking Obesity with Colorectal Cancer Risk in Postmenopausal Women
Ho, G. Y. F., Wang, T., Gunter, M. J., Strickler, H. D., Cushman, M., Kaplan, R. C., Wassertheil‐Smoller, S., Xue, X., Rajpathak, S. N., Chlebowski, R. T., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2771 · Cited by 153
Psoriasis and comorbidities: links and risks
Chiu, M. W., & Ni, C. S. (2014) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s44843 · Cited by 156
Santhakumar, A. B., Bulmer, A. C., & Singh, I. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12177 · Cited by 159
Genetics of human Bardet–Biedl syndrome, an updates
Khan, S. A., Muhammad, N., Khan, M. A., Kamal, A., Rehman, Z. U., & Khan, S. A. (2016) · Clinical Genetics · doi:10.1111/cge.12737 · Cited by 162
Role of diet and gut microbiota on colorectal cancer immunomodulation
Almeida, C. V. D., de Camargo, M. R., Russo, E., & Amedei, A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i2.151 · Cited by 160
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
Wandrer, F., Liebig, S., Marhenke, S., Vogel, A., John, K., Manns, M. P., Teufel, A., Itzel, T., Longerich, T., Maier, O., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2411-6 · Cited by 156
The Genetic Basis of Type 2 Diabetes.
Das, S. K., & Elbein, S. C. (2006) · PubMed · doi:10.1901/jaba.2006.2-100 · Cited by 153
Peterson, S. J., Drummond, G., Kim, D. H., Li, M., Kruger, A. L., Ikehara, S., & Abraham, N. G. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800046-jlr200 · Cited by 153
Chmielewski, P. P., & Strzelec, B. (2017) · Folia Morphologica · doi:10.5603/fm.a2017.0101 · Cited by 157
Gut Microbiota and Its Mysteries
Pushpanathan, P., Mathew, G. S., Selvarajan, S., Seshadri, K., & Srikanth, P. (2019) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_19_373 · Cited by 162
Therapeutic approaches for muscle wasting disorders
Lynch, G. S., Schertzer, J. D., & Ryall, J. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.004 · Cited by 155
Guri, A. J., Hontecillas, R., Si, H., Liu, D., & Bassaganya-Riera, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.07.008 · Cited by 156
Goren, I., Müller, E., Schiefelbein, D., Christen, U., Pfeilschifter, J., Mühl, H., & Frank, S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700842 · Cited by 151
IL‐10 prevents aging‐associated inflammation and insulin resistance in skeletal muscle
Dağdeviren, S., Jung, D. Y., Friedline, R. H., Noh, H. L., Kim, J. H., Patel, P. R., Tsitsilianos, N., Inashima, K., Tran, D. A., Hu, X., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600832r · Cited by 151
The pathophysiology of obesity and its clinical manifestations.
Redinger, R. N. (2007) · PubMed Central · Cited by 151
Wronkowitz, N., Görgens, S. W., Romacho, T., Villalobos, L. A., Sánchez‐Ferrer, C. F., Peiró, C., Sell, H., & Eckel, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.004 · Cited by 154
Uemura, T., Hirai, S., Mizoguchi, N., Goto, T., Lee, J., Taketani, K., Nakano, Y., Shono, J., Hoshino, S., Tsuge, N., et al. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900609 · Cited by 150
Mowers, J. C., Uhm, M., Reilly, S. M., Simon, J., Leto, D. E., Chiang, S.-H., Chang, L. C., & Saltiel, A. R. (2013) · eLife · doi:10.7554/elife.01119 · Cited by 152
Chen, X., Chen, C., & Fu, X. (2022) · Food & Function · doi:10.1039/d2fo02300h · Cited by 157
Chen, X., Chen, C., & Fu, X. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c02429 · Cited by 158
Age-related inflammation and insulin resistance: a review of their intricate interdependency
Park, M. H., Kim, D. H., Lee, E. K., Kim, N. D., Im, D., Lee, J., Yu, B. P., & Chung, H. Y. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0474-6 · Cited by 152
Toll-like receptors, inflammation, metabolism and obesity
Fresno, M., Álvarez, R., & Cuesta, N. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.562514 · Cited by 150
Shen, Y. H., Zhang, L., Gan, Y., Wang, X., Wang, J., LeMaire, S. A., Coselli, J. S., & Wang, X. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511105200 · Cited by 148
Type‐2 diabetes: Current understanding and future perspectives
Pandey, A., Chawla, S., & Guchhait, P. (2015) · IUBMB Life · doi:10.1002/iub.1396 · Cited by 162
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population
Bhole, V., Choi, H. K., Burns, L. C., Vera‐Kellet, C., Lacaille, D., Gladman, D. D., & Dutz, J. P. (2011) · Rheumatology · doi:10.1093/rheumatology/ker349 · Cited by 146
p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis
Cao, W., Collins, Q. F., Becker, T. C., Robidoux, J., Lupo, E. G., Xiong, Y., Daniel, K. W., Floering, L. M., & Collins, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506223200 · Cited by 145
Diet, gut microbiota and cognition
Proctor, C., Thiennimitr, P., Chattipakorn, N., & Chattipakorn, S. C. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9917-8 · Cited by 144
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies
Al-Attas, O. S., Al‐Daghri, N. M., Al-Rubeaan, K. A., da Silva, N. F., Sabico, S., Kumar, S., McTernan, P. G., & Harte, A. L. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-20 · Cited by 145
Schattenberg, J. M., Galle, P. R., & Schuchmann, M. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01324.x · Cited by 144
Role of T Cells in Malnutrition and Obesity
Gerriets, V. A., & MacIver, N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00379 · Cited by 154
Tiffin, N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl381 · Cited by 148
Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., & Fairlie, D. P. (2012) · The FASEB Journal · doi:10.1096/fj.12-220582 · Cited by 146
The association of type II diabetes with gut microbiota composition
Navab-Moghadam, F., Sedighi, M., Khamseh, M. E., Alaei-Shahmiri, F., Talebi, M., Razavi, S., & Amirmozafari, N. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.07.034 · Cited by 149
Monte, S. V., Caruana, J. A., Ghanim, H., Sia, C. L., Korzeniewski, K., Schentag, J. J., & Dandona, P. (2012) · Surgery · doi:10.1016/j.surg.2011.09.038 · Cited by 143
COMPANION ANIMALS SYMPOSIUM: Obesity in dogs and cats: What is wrong with being fat?1
Laflamme, D. P. (2011) · Journal of Animal Science · doi:10.2527/jas.2011-4571 · Cited by 152
HPA-axis and inflammatory reactivity to acute stress is related with basal HPA-axis activity
Chen, X., Gianferante, D., Hanlin, L. C., Fiksdal, A. S., Breines, J. G., Thoma, M. V., & Rohleder, N. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.035 · Cited by 157
‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
Lonardo, A., Carani, C., Carulli, N., & Loria, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.005 · Cited by 145
Lymphotoxin regulates commensal responses to enable diet-induced obesity
Upadhyay, V., Poroyko, V. A., Kim, T.-J., Devkota, S., Fu, S., Liu, D., Tumanov, A. V., Koroleva, E. P., Deng, L., Nagler‐Anderson, C., et al. (2012) · Nature Immunology · doi:10.1038/ni.2403 · Cited by 145
TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
Ti, Y., Xie, G.-L., Wang, Z., Bi, X., Ding, W., Wang, J., Jiang, G.-H., Bu, P. L., Zhang, Y., Zhong, M., et al. (2011) · Diabetes · doi:10.2337/db11-0549 · Cited by 141
Benefits of flu vaccination for persons with diabetes mellitus: A review
Goeijenbier, M., van Sloten, T. T., Slobbe, L., Mathieu, C., van Genderen, P. J. J., BEYER, W. E. P., & Osterhaus, A. D. M. E. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.095 · Cited by 143
Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications
Landon, R., Gueguen, V., Petite, H., Letourneur, D., Pavon‐Djavid, G., & Anagnostou, F. (2020) · Marine Drugs · doi:10.3390/md18070357 · Cited by 146
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: An update
Zhang, H., Dellsperger, K. C., & Zhang, C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0237-1 · Cited by 144
New insights into insulin resistance in the diabetic heart
Gray, S., & Kim, J. K. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.05.001 · Cited by 147
Polyphenols and type 2 diabetes: A prospective review
Anhê, F. F., Desjardins, Y., Pilon, G., Dudonné, S., Genovese, M. I., Lajolo, F. M., & Marette, A. (2013) · PharmaNutrition · doi:10.1016/j.phanu.2013.07.004 · Cited by 150
Lee, J. Y., Zhao, L., & Hwang, D. H. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00259.x · Cited by 147
E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis
Denechaud, P., López‐Mejía, I. C., Giralt, A., Lai, Q., Blanchet, É., Delacuisine, B., Nicolay, B., Dyson, N. J., Bonner, C., Pattou, F. N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81542 · Cited by 150
Effectiveness of probiotics in type 2 diabetes: a meta-analysis
Kasińska, M., & Drzewoski, J. (2015) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3156 · Cited by 144
Sirtuins and Insulin Resistance
Zhou, S., Tang, X., & Chen, H. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00748 · Cited by 155
Liao, W., Nguyen, M. T., Yoshizaki, T., Favelyukis, S., Patsouris, D., Imamura, T., Verma, I. M., & Olefsky, J. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00695.2006 · Cited by 149
Kim, S., Joe, Y., Kim, H. J., Kim, Y., Jeong, S. O., Pae, H., Ryter, S. W., Surh, Y., & Chung, H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401399 · Cited by 139
ROWLANDS, D. S., Page, R., Sukala, W. R., Giri, M., Ghimbovschi, S. D., Hayat, I., Cheema, B. S., Lys, I., Leikis, M. J., Sheard, P., et al. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2014 · Cited by 144
Prasad, S., Sajja, R. K., Kaisar, M. A., Park, J. H., Villalba, H., Liles, T., Abbruscato, T. J., & Cucullo, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.007 · Cited by 138
Григорьевна, О. Р., Golovchenko, V. V., Popov, S. V., POPOVA, G., Михайлович, П. Н., Shashkov, A. S., & Ovodov, Y. S. (2008) · Food Chemistry · doi:10.1016/j.foodchem.2008.09.094 · Cited by 140
Necela, B. M., Su, W., & Thompson, E. A. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02849.x · Cited by 140
Joosten, M. M., Beulens, J. W. J., Kersten, S., & Hendriks, H. F. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1031-y · Cited by 180
Karnieli, E., & Armoni, M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90306.2008 · Cited by 144
Diabetic Retinopathy and Diabetic Macular Edema
Cohen, S. R., & Gardner, T. W. (2015) · Developments in ophthalmology · doi:10.1159/000438970 · Cited by 141
Zhang, B., Sun, W., Yu, N., Sun, J., Yu, X., Li, X., Xing, Y., Yan, D., Ding, Q., Xiu, Z., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.070 · Cited by 139
Sutton, G. M., Trevaskis, J. L., Hulver, M. W., McMillan, R. P., Markward, N., Babin, M. J., Meyer, E. A., & Butler, A. A. (2006) · Endocrinology · doi:10.1210/en.2005-1209 · Cited by 141
Muhammad, H. F. L., van Baak, M. A., Mariman, E. C. M., Sulistyoningrum, D. C., Huriyati, E., Lee, Y. Y., & Muda, W. A. M. W. (2019) · Nutrients · doi:10.3390/nu11010148 · Cited by 142
Su, B., Liu, H., Li, J., Sunli, Y., Liu, B., Liu, D., Zhang, P., & Meng, X. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12232 · Cited by 136
Fadini, G. P., de Kreutzenberg, S. V., Boscaro, E., Albiero, M., Cappellari, R., Kränkel, N., Landmesser, U., Toniolo, A., Bolego, C., Cignarella, A., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2918-9 · Cited by 141
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M. A., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 140
Diamanti‐Kandarakis, E. (2006) · Endocrine · doi:10.1385/endo:30:1:13 · Cited by 137
Acupuncture: is it effective for treatment of insulin resistance?
Liang, F.-X., & Koya, D. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01192.x · Cited by 137
Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota
Kang, Y., Li, Y., Du, Y., Guo, L., Chen, M., Huang, X., Fang, Y., Hong, J., & Kong, X. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0187-x · Cited by 136
Fülöp, T., Tessier, D., & Carpentier, A. C. (2006) · Pathologie Biologie · doi:10.1016/j.patbio.2006.07.002 · Cited by 144
Adipocyte Modulation of High-Density Lipoprotein Cholesterol
Zhang, Y., McGillicuddy, F. C., Hinkle, C. C., O'Neill, S., Glick, J. M., Rothblat, G. H., & Reilly, M. P. (2010) · Circulation · doi:10.1161/circulationaha.109.897330 · Cited by 135
Weight loss is a critical factor to reduce inflammation
Bianchi, V. E. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.08.007 · Cited by 142
Overview of anti-inflammatory diets and their promising effects on non-communicable diseases
Yu, X., Pu, H., & Voss, M. (2024) · British Journal of Nutrition · doi:10.1017/s0007114524001405 · Cited by 134
Targeting gut microbiota as a possible therapy for diabetes
He, C., Shan, Y., & Song, W. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.03.002 · Cited by 139
Gregersen, S., Samocha‐Bonet, D., Heilbronn, L. K., & Campbell, L. V. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/238056 · Cited by 136
Olvera Alvarez, H. A., Kubzansky, L. D., Campen, M. J., & Slavich, G. M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.002 · Cited by 133
“Second, many of these diseases have an underlying inflammatory component (Danese et al., 2009; O’Neill et al., 2007; Slavich and Irwin, 2014; Wellen and Hotamisligil, 2005).”
Azfar, R. S., Seminara, N. M., Shin, D. B., Troxel, A. B., Margolis, D. J., & Gelfand, J. M. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2012.1401 · Cited by 135
Szpigel, A., Hainault, I., Carlier, A., Venteclef, N., Batto, A.-F., Hajduch, É., Bernard, C., Ktorza, A., Gautier, J., Ferré, P., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4462-5 · Cited by 138
El‐Saadony, M. T., Saad, A. M., Mohammed, D. M., Alkafaas, S. S., Ghosh, S. B., Negm, S. H., Salem, H. M., Fahmy, M. A., Mosa, W. F. A., Ibrahim, E. H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603018 · Cited by 155
Shin, J. H., Shin, D. W., & Noh, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.008 · Cited by 140
Tremblay, A. J., Lamarche, B., Deacon, C. F., Weisnagel, S. J., & Couture, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.06.004 · Cited by 132
Role of interleukins in obesity: implications for metabolic disease
Febbraio, M. A. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.02.004 · Cited by 134
Neuroendocrine‐immune crosstalk in vertebrates and invertebrates: implications for host defence
Demas, G. E., Adamo, S. A., & French, S. S. (2010) · Functional Ecology · doi:10.1111/j.1365-2435.2010.01738.x · Cited by 132
Li, G., Barrett, E. J., Barrett, M. O., Cao, W., & Liu, Z. (2007) · Endocrinology · doi:10.1210/en.2006-1441 · Cited by 131
Low-grade chronic inflammation perpetuated by modern diet as a promoter of obesity and osteoporosis
Ilich, J. Z., Kelly, O. J., Kim, Y. J., & Spicer, M. T. (2014) · Archives of Industrial Hygiene and Toxicology · doi:10.2478/10004-1254-65-2014-2541 · Cited by 134
Nilsson, A. C., Johansson, E., Ekström, L. M. N. K., & Björck, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059985 · Cited by 130
Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases
Choi, A. J. S., & Ryter, S. W. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.0104 · Cited by 132
Otoda, T., Takamura, T., Misu, H., Ota, T., Murata, S., Hayashi, H., Takayama, H., Kikuchi, A., Kanamori, T., Shima, K. R., et al. (2012) · Diabetes · doi:10.2337/db11-1652 · Cited by 134
Interleukin-1 beta targeted therapy for type 2 diabetes
Maedler, K., Dharmadhikari, G., Schumann, D., & Størling, J. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903136688 · Cited by 132
Hou, Y., Xue, P., Bai, Y., Liu, D., Woods, C. G., Yarborough, K., Fu, J., Zhang, Q., Sun, G., Collins, S., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.453 · Cited by 131
Metadata
- Authors
- Wellen, K. E., & Hotamisligil, G. S.
- Affiliations
- Harvard University (US)
- ORCID
- Wellen, Kathryn E.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-05-02
- Volume
- 115
- Issue
- 5
- Pages
- 1111-1119
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1087185
- OpenAlex
- W2064119981
- Cited by
- 4,143
- References
- 118
- Citations by year
- 2026: 76 · 2025: 104 · 2024: 92 · 2023: 130 · 2022: 177 · 2021: 169 · 2020: 209 · 2019: 221 · 2018: 233 · 2017: 193 · 2016: 215 · 2015: 226 · 2014: 239 · 2013: 276 · 2012: 264
- FWCI
- 138.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- obesity-associated inflammation, low-grade inflammation, type 2 diabetes, insulin signaling, stress response, innate immunity, innate lymphoid cells, Th17 cells, Th1 cells, Th2 cells, regulatory T cells, Treg cell function, Treg cell homeostasis
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Inflammation, Insulin Resistance, Macrophages, Obesity, Stress, Physiological, Adipocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review